MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Establishment Labs Holdings Inc

Closed

SectorHealthcare

41.42 -2.82

Overview

Share price change

24h

Current

Min

41.42

Max

43.29

Key metrics

By Trading Economics

Income

14M

-21M

Sales

-3.1M

41M

Profit margin

-50.052

Employees

1,034

EBITDA

11M

-17M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+32.25% upside

Dividends

By Dow Jones

Next Earnings

5 Aug 2025

Market Stats

By TradingEconomics

Market Cap

317M

1.3B

Previous open

44.24

Previous close

41.42

News Sentiment

By Acuity

60%

40%

316 / 376 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Establishment Labs Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Oct 2024, 16:43 UTC

Major Market Movers

Establishment Labs Shares Climb on High Demand for FDA-Approved Breast Motiva Implants

27 Sept 2024, 10:33 UTC

Major Market Movers

Establishment Labs Shares Surge Premarket on FDA Breast Implant Approval

Peer Comparison

Price change

Establishment Labs Holdings Inc Forecast

Price Target

By TipRanks

32.25% upside

12 Months Forecast

Average 56.14 USD  32.25%

High 70 USD

Low 45 USD

Based on 7 Wall Street analysts offering 12 month price targets forEstablishment Labs Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

30.5 / N/ASupport & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

316 / 376 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.